Johnson & Johnson (Pty) LtdDePuy Synthes group announced on 19 January it received US Food and Drug Administration 510(k) clearance for its Velys robotic-assisted solution for total knee arthroplasty, which will rival existing orthopedic robotic offerings by major competitors Stryker Corporation, Zimmer Biomet Holdings, Inc. and Smith & Nephew plc. (Also see "Role Of Digital Surgery Will Continue To Grow Despite Cost Constraints" - Medtech Insight, 8 October, 2020.)
The initial clearance for Velys will be for total knee arthroplasty using DePuy’s Attune Total Knee System. The company plans...
Welcome to Medtech Insight
Create an account to read this article
Already a subscriber?